Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 11;40(4):424-437.e5.
doi: 10.1016/j.ccell.2022.02.013. Epub 2022 Mar 17.

Immune phenotypic linkage between colorectal cancer and liver metastasis

Affiliations
Free article

Immune phenotypic linkage between colorectal cancer and liver metastasis

Yedan Liu et al. Cancer Cell. .
Free article

Abstract

The tumor microenvironment (TME) is connected to immunotherapy responses, but it remains unclear how cancer cells and host tissues differentially influence the immune composition within TME. Here, we performed single-cell analyses for autologous samples from liver metastasized colorectal cancer to disentangle factors shaping TME. By aligning CD45+ cells across different tissues, we classified exhausted CD8+ T cells (Texs) and activated regulatory T cells as M-type, whose phenotypes were associated with the malignancy, while natural killer and mucosal-associated invariant T cells were defined as N-type, whose phenotypes were associated with the niche. T cell receptor sharing between Texs in primary and metastatic tumors implicated the presence of common peripheral non-exhausted precursors. For myeloid cells, a subset of dendritic cells (DC3s) and SPP1+ macrophages were M-type, and the latter were predominant in liver metastasis, indicating its pro-metastasis role. Our analyses bridge immune phenotypes of primary and metastatic tumors, thereby helping to understand the tumor-specific contexture and identify the pro-metastasis components.

Keywords: CRC liver metastasis; scRNA-seq; tumor infiltrating; tumor microenvironment.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests Z.Z. is a founder of Analytical Biosciences and a member of its scientific advisory board. Z.Z. is also a consultant for GennLife and InnoCare Pharma. X.H. and R.G. are employees of Analytical Biosciences. All financial interests are unrelated to this study. The other authors declare no competing interests.

Comment in

Publication types